{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:32:52Z","timestamp":1792186372651,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.actatropica.2023.106960","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T10:51:29Z","timestamp":1685789489000},"page":"106960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Challenges in the treatment and prevention of monkeypox infection; A comprehensive review"],"prefix":"10.1016","volume":"245","author":[{"given":"Jennifer","family":"Nyame","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0802-7999","authenticated-orcid":false,"given":"Saranya","family":"Punniyakotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanav","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi Saxena","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Varadarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2023.106960_bib0003","unstructured":"ACAM2000 [Package Insert]. Gaithersburg, MD: Emergent Product Development Gaithersburg Inc 2007. https:\/\/www.fda.gov\/media\/75792\/download."},{"issue":"8","key":"10.1016\/j.actatropica.2023.106960_bib0004","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK [published correction appears in Lancet Infect Dis. 2022 Jul;22(7):e177] [published correction appears in Lancet Infect Dis. 2022 Jul;22(7):e177]","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.actatropica.2023.106960_bib0005","doi-asserted-by":"crossref","first-page":"e01587","DOI":"10.1016\/j.idcr.2022.e01587","article-title":"Monkeypox - an emerging pandemic","volume":"29","author":"Ajmera","year":"2022","journal-title":"IDCases"},{"issue":"11","key":"10.1016\/j.actatropica.2023.106960_bib0006","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/v12111257","article-title":"Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution","volume":"12","author":"Alakunle","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.actatropica.2023.106960_bib0007","unstructured":"B. NEWS. Monkeypox, two more confirmed cases of viral infection, 2022."},{"issue":"10","key":"10.1016\/j.actatropica.2023.106960_bib0008","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S1474-4422(22)00340-4","article-title":"Potential complications of monkeypox","volume":"21","author":"Billioux","year":"2022","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.actatropica.2023.106960_bib0009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1358\/dot.2010.46.2.1437244","article-title":"Tecovirimat for smallpox infections","volume":"46","author":"Bolken","year":"2010","journal-title":"Drugs Today Barc."},{"key":"10.1016\/j.actatropica.2023.106960_bib0010","unstructured":"H. Branswell, Genetic Data indicate at least two separate monkeypox outbreaks."},{"issue":"2","key":"10.1016\/j.actatropica.2023.106960_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox-A potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.actatropica.2023.106960_bib0012","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/all.15633","article-title":"A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak","volume":"78","author":"Cabanillas","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.actatropica.2023.106960_bib0013","unstructured":"Center for Disease Control and Prevention, Monitoring people who have been exposed, https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/monitoring.html."},{"issue":"7","key":"10.1016\/j.actatropica.2023.106960_bib0014","first-page":"e26756","article-title":"Monkeypox: a review of clinical features, diagnosis, and treatment","volume":"14","author":"Cheema","year":"2022","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.actatropica.2023.106960_bib0015","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1128\/AAC.00904-12","article-title":"Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers","volume":"56","author":"Chinsangaram","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.actatropica.2023.106960_bib0016","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/v2061322","article-title":"Historical perspectives in the development of antiviral agents against poxviruses","volume":"2","author":"De Clercq","year":"2010","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.actatropica.2023.106960_bib0017","doi-asserted-by":"crossref","first-page":"306","DOI":"10.15585\/mmwr.mm6710a5","article-title":"Emergence of monkeypox - West and Central Africa, 1970-2017 [published correction appears in MMWR Morb Mortal Wkly Rep. 2018 Apr 27;67(16):479]","volume":"67","author":"Durski","year":"2018","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.actatropica.2023.106960_bib0018","doi-asserted-by":"crossref","first-page":"o1314","DOI":"10.1136\/bmj.o1314","article-title":"Investigating the monkeypox outbreak","volume":"377","author":"Dye","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.actatropica.2023.106960_bib0019","unstructured":"J. Faus Spain reports the second monkeypox-related death in Europe. https:\/\/www.reuters.com\/world\/europe\/spainconfirms-first-monkeypox-related-death-countryreports-2022-07-29\/."},{"key":"10.1016\/j.actatropica.2023.106960_bib0002","unstructured":"(FDA).USFDA.Highlightsofprescribinginformationtpoxx\u00aesafelyandeffectively [Availablefrom: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/214518s000lbl.pdf."},{"issue":"3","key":"10.1016\/j.actatropica.2023.106960_bib0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int. J. Epidemiol."},{"issue":"11","key":"10.1016\/j.actatropica.2023.106960_bib0021","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/v9110320","article-title":"The role of brincidofovir in preparation for a potential smallpox outbreak","volume":"9","author":"Foster","year":"2017","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.actatropica.2023.106960_bib0022","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-neutralizing and protective human antibody specificities to poxvirus infections","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.actatropica.2023.106960_bib0023","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2471\/BLT.19.242347","article-title":"Modelling human-to-human transmission of monkeypox","volume":"98","author":"Grant","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.actatropica.2023.106960_bib0024","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2471\/BLT.19.242347","article-title":"Modelling human-to-human transmission of monkeypox","volume":"98","author":"Grant","year":"2020","journal-title":"Bull. World Health Organ."},{"issue":"1","key":"10.1016\/j.actatropica.2023.106960_bib0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral tecovirimat for the treatment of smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.actatropica.2023.106960_bib0026","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm1273","article-title":"Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox","volume":"11","author":"Hammarlund","year":"2005","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.actatropica.2023.106960_bib0027","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jinf.2022.05.028","article-title":"Transmission of monkeypox virus through sexual contact - a novel route of infection","volume":"85","author":"Heskin","year":"2022","journal-title":"J. Infect."},{"issue":"3","key":"10.1016\/j.actatropica.2023.106960_bib0028","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/oxfordjournals.bmb.a011720","article-title":"Re-emergence of monkeypox in Africa: a review of the past six years","volume":"54","author":"Heymann","year":"1998","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.actatropica.2023.106960_bib0029","doi-asserted-by":"crossref","unstructured":"S.M.T Hoy: First global approval drugs 2018, 78, 1377\u20131382.","DOI":"10.1007\/s40265-018-0967-6"},{"issue":"1","key":"10.1016\/j.actatropica.2023.106960_bib0030","first-page":"e00927","article-title":"Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model [published correction appears in mSphere. 2021 Feb 17;6(1):]","volume":"6","author":"Hutson","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.actatropica.2023.106960_bib0063","unstructured":"Institute of medicine (us) committee on emerging microbial threats to health in the 21st Century, Smolinski M.S., Hamburg M.A., Lederberg J., eds. Microbial Threats to Health: Emergence, Detection, and Response. Washington (DC): National Academies Press (US); 2003."},{"issue":"2","key":"10.1016\/j.actatropica.2023.106960_bib0031","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.actatropica.2023.106960_bib0032","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.01303-07","article-title":"Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor","volume":"52","author":"Jordan","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2023.106960_bib0033","unstructured":"JYNNEOS [Package Insert]. Kvistg\u00e5rd, Denmark: bavarian Nordic A\/S: 2019. https:\/\/www.fda.gov\/media\/131078\/download."},{"issue":"7","key":"10.1016\/j.actatropica.2023.106960_bib0034","first-page":"e26531","article-title":"Monkeypox: a Comprehensive Review of Transmission","volume":"14","author":"Kaler","year":"2022","journal-title":"Pathogenesis Manifestation. Cureus"},{"issue":"16","key":"10.1016\/j.actatropica.2023.106960_bib0035","first-page":"5983","article-title":"Monkeypox: epidemiology, mode of transmission, clinical features, genetic clades, and molecular properties","volume":"26","author":"Kannan","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.actatropica.2023.106960_bib0037","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3201\/eid2002.130118","article-title":"Genomic variability of monkeypox virus among humans, democratic republic of the congo","volume":"20","author":"Kugelman","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.actatropica.2023.106960_bib0038","unstructured":"K. Kupferschmidt As monkeypox threat grows, scientists debate best vaccine strategy."},{"issue":"2","key":"10.1016\/j.actatropica.2023.106960_bib0039","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001432-200404000-00003","article-title":"Zoonotic poxvirus infections in humans","volume":"17","author":"Lewis-Jones","year":"2004","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2023.106960_bib0040","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1086\/595552","article-title":"Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity","volume":"48","author":"Macneil","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.actatropica.2023.106960_bib0041","first-page":"599","article-title":"Isolation and properties of the causal agent of a new variola-like disease monkeypox in man","volume":"46","author":"Marennikova","year":"1972","journal-title":"Bull. World Health Organ."},{"issue":"24","key":"10.1016\/j.actatropica.2023.106960_bib0042","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMc2210015","article-title":"Tecovirimat for monkeypox in central African Republic under Expanded Access","volume":"387","author":"Mbrenga","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.actatropica.2023.106960_bib0043","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/14787210.2022.2113058","article-title":"Therapeutic strategies to address monkeypox","volume":"20","author":"McCarthy","year":"2022","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"1","key":"10.1016\/j.actatropica.2023.106960_bib0044","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/vaccines6010008","article-title":"Challenges and achievements in prevention and treatment of smallpox","volume":"6","author":"Melamed","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.actatropica.2023.106960_bib0045","unstructured":"Monkeypox Cases Confirmed in England \u2013 Latest Updates, UK Health SecurityAgency (UKHSA), 2022."},{"key":"10.1016\/j.actatropica.2023.106960_bib0046","doi-asserted-by":"crossref","first-page":"o1321","DOI":"10.1136\/bmj.o1321","article-title":"Waking up to monkeypox","volume":"377","author":"Nakoune","year":"2022","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.actatropica.2023.106960_bib0048","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1093\/cid\/ciaa143","article-title":"Clinical course and outcome of human monkeypox in Nigeria","volume":"71","author":"Ogoina","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.actatropica.2023.106960_bib0049","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ana.26473","article-title":"An overview of monkeypox virus and its neuroinvasive potential","volume":"92","author":"Pastula","year":"2022","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.actatropica.2023.106960_bib0050","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.idc.2019.03.001","article-title":"Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention","volume":"33","author":"Petersen","year":"2019","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.actatropica.2023.106960_bib0051","article-title":"Prevention of monkeypox with vaccines: a rapid review [published online ahead of print, 2022 Sep 15]","author":"Poland","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.actatropica.2023.106960_bib0052","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.00879-06","article-title":"Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice","volume":"51","author":"Quenelle","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2023.106960_bib0053","unstructured":"REUTERS. Factbox, Monkeypox cases around the world, 2022."},{"issue":"2","key":"10.1016\/j.actatropica.2023.106960_bib0054","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/14787210.2019.1567330","article-title":"Monkeypox re-emergence in Africa: a call to expand the concept and practice of One Health","volume":"17","author":"Reynolds","year":"2019","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"2","key":"10.1016\/j.actatropica.2023.106960_bib0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/v3020063","article-title":"Efficacy of CMX001 as a prophylactic and presymptomatic antiviral agent in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans","volume":"3","author":"Rice","year":"2011","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.actatropica.2023.106960_bib0056","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","article-title":"Prevention and treatment of monkeypox [published correction appears in Drugs. 2022 Aug;82(12):1343]","volume":"82","author":"Rizk","year":"2022","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.actatropica.2023.106960_bib0057","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","article-title":"An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications","volume":"19","author":"Russo","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.actatropica.2023.106960_bib0059","article-title":"Re-emerging human monkeypox: a major public-health debacle [published online ahead of print, 2022 Jun 1]","author":"Saxena","year":"2022","journal-title":"J. Med. Virol."},{"issue":"4","key":"10.1016\/j.actatropica.2023.106960_bib0060","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4269\/ajtmh.2007.76.768","article-title":"Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection","volume":"76","author":"Sbrana","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2023.106960_bib0061","series-title":"Orthopoxviruses Pathogenic for Humans","first-page":"425","author":"Shchelkunov","year":"2005"},{"key":"10.1016\/j.actatropica.2023.106960_bib0062","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/v13010043","article-title":"There, and everywhere: the wide host range and geographic distribution of zoonotic orthopoxviruses","volume":"13","author":"Silva","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.actatropica.2023.106960_bib0064","doi-asserted-by":"crossref","first-page":"297","DOI":"10.18433\/jpps33138","article-title":"Monkeypox: virology, pathophysiology, clinical characteristics, epidemiology, vaccines, diagnosis, and treatments","volume":"25","author":"Soheili","year":"2022","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.actatropica.2023.106960_bib0065","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/JVI.02012-09","article-title":"A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus","volume":"84","author":"Stabenow","year":"2010","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.actatropica.2023.106960_bib0066","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 Countries - April-June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2023.106960_bib0067","series-title":"Suggesting Wider Spread","year":"2022"},{"key":"10.1016\/j.actatropica.2023.106960_bib0068","unstructured":"USFDA. Highlights of prescribing information-cnj-016, vaccinia immune globulin intravenous (Human), sterile solution. Available from: https:\/\/www.fda.gov\/media\/78174\/download."},{"key":"10.1016\/j.actatropica.2023.106960_bib0069","unstructured":"Vaccines\u2014Smallpox. https:\/\/www.cdc.gov\/smallpox\/clinicians\/vaccines.html."},{"issue":"7","key":"10.1016\/j.actatropica.2023.106960_bib0070","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/tmi.13785","article-title":"Monkeypox 2022 outbreak: an update","volume":"27","author":"Velavan","year":"2022","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.actatropica.2023.106960_bib0071","series-title":"Informal Consultation on Monkeypox 2017","year":"2017"},{"issue":"20","key":"10.1016\/j.actatropica.2023.106960_bib0072","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X2300147X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X2300147X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:41:57Z","timestamp":1757551317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X2300147X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":68,"alternative-id":["S0001706X2300147X"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2023.106960","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in the treatment and prevention of monkeypox infection; A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2023.106960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106960"}}